Market Overview - The small home appliance sector increased by 0.44% on October 15, with BeiYikang leading the gains [1] - The Shanghai Composite Index closed at 3912.21, up 1.22%, while the Shenzhen Component Index closed at 13118.75, up 1.73% [1] Stock Performance - BeiYikang (code: 6610Z6) closed at 38.15, rising by 4.72% with a trading volume of 26,900 lots and a transaction value of 102 million yuan [1] - Other notable performers include: - Aishida (code: 002403) at 14.57, up 3.26% [1] - Ousheng Electric (code: 301187) at 26.48, up 2.20% [1] - Kaineng Health (code: 300272) at 6.56, up 2.18% [1] - Delma (code: 301332) at 9.88, up 1.96% [1] Capital Flow - The small home appliance sector experienced a net outflow of 115 million yuan from institutional investors, while retail investors saw a net inflow of 94.22 million yuan [2] - The capital flow for specific stocks includes: - Xinbao (code: 002705) with a net inflow of 12.21% from institutional investors [3] - Feike Electric (code: 603868) with a net inflow of 18.64% from retail investors [3] - Kaineng Health (code: 300272) with a net outflow of 1.35% from retail investors [3]

证券代码：300272 证券简称：开能健康 公告编号：2025-085 近日，公司根据经营情况在上述使用期限及额度内，使用部分闲置募集资金 进行了现金管理，现将具体情况公告如下： 一、理财产品基本情况 购买情况： | 购买 | 发行主体 | 产品名称 | 产品类型 | 金额 | 产品期限 | | 预计年化收 | | --- | --- | --- | --- | --- | --- | --- | --- | | 主体 | | | | （万元） | | | 益率 | | | | | | | 2025 月 9 | | | | | | 兴业银行企业 | | | | 年 10 | | | 开能 | 兴业银行上 | 金融人民币结 | 保本浮动 | 6,500 | | 日至 | 1.0%-1.75% | | 健康 | 海分行 | | 收益型 | | 2025 | 年 12 | | | | | 构性存款产品 | | | | | | | | | | | | 月 25 | 日 | | 赎回情况： | 购买 | 发行主体 | 产品名称 | 产品类型 | 金额 | 收益金额 | 公告编 | | --- | --- | --- | ...

Core Insights - The company, Kaineng Health, reported that as of September 30, 2025, the total number of shareholders is 21,993 [1] Summary by Category - **Company Information** - Kaineng Health has a total of 21,993 shareholders as of the specified date [1]

证券代码：300272 证券简称：开能健康 公告编号：2025-083 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或者重大遗漏。 特别提示 1、本次股东大会召开期间没有增加、否决或者变更议案的情况发生； 2、本次股东大会不存在变更前次股东大会决议的情形。 一、会议的召开和出席情况 （一）会议召开情况 通过深交所交易系统进行网络投票的时间为2025年9月29日9:15-9:25、9:30-11:30 和13:00-15:00； 通过互联网投票系统投票的时间为2025年9月29日上午9:15-下午15:00期间任意时 间。 1、会议召开的时间 （1）现场会议时间：2025年9月29日下午2:30开始 （2）网络投票时间： 1.00《关于修订<公司章程>并变更公司注册资本的议案》； | | 参加表决股数 | 赞成股数（股） | 比例 | 反对股数 | 比例（%） | 弃权股数 | 比例 | | --- | --- | --- | --- | --- | --- | --- | --- | | | （股） | | （%） | （股） | | （股） | （%） | | 总体表 ...

开能健康科技集团股份有限公司 关于选举产生第六届董事会职工代表董事的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，不存在虚假记 载、误导性陈述或者重大遗漏。 一、选举第六届董事会职工代表董事的情况 证券代码：300272 证券简称：开能健康 公告编号：2025-084 JINFENG（金凤）女士符合《公司法》《深圳证券交易所上市公司自律监管 指引第2号——创业板上市公司规范运作》《公司章程》规定的有关职工代表董事 任职资格。JINFENG（金凤）女士担任公司职工代表董事后，公司第六届董事会 中兼任公司高级管理人员的董事以及由职工代表担任的董事人数总计未超过董 事总数的二分之一，符合相关法律法规的要求。 二、备查文件 附件： 开能健康科技集团股份有限公司 开能健康科技集团股份有限公司（以下简称"公司 "或"本公司"）于2025 年9月10日召开的第六届董事会第二十六次会议审议通过了《关于修订<公司章 程>并变更公司注册资本的议案》以及《关于修订公司部分制度的议案》。根据中 国证券监督管理委员会发布的《关于新<公司法>配套制度规则实施相关过渡期 安排》《上市公司章程指引》等相关法律法规的规定，结合实际 ...

国浩律师（上海）事务所 临时股东大会法律意见书 国浩律师(上海)事务所 Grandall Law Firm (Shanghai) 中国 上海 山西北路 99 号苏河湾中心 25-28 楼，200085 25-28/F, Suhe Centre, 99 North Shanxi Road, Shanghai 200085, China 电话/TEL.: (+86)(21) 5234 1668 传真/FAX: (+86)(21) 5243 3320 国浩律师（上海）事务所 关于开能健康科技集团股份有限公司 2025 年第二次临时股东大会的 法律意见书 致：开能健康科技集团股份有限公司 根据出席现场会议股东的签名及授权委托书，出席现场会议的股东及股东代 表 15 人，代表公司股份 151,216,952 股，占公司有表决权股份总数的 27.1417%。 根据《中华人民共和国公司法》（以下简称"《公司法》"）《中华人民共和国 证券法》（以下简称"《证券法》"）和《上市公司股东会规则》（以下简称"《股东 会规则》"）的规定，国浩律师（上海）事务所（以下简称"本所"）接受开能健 康科技集团股份有限公司（以下简称"公司"） ...

Market Overview - The small home appliance sector experienced a decline of 0.42% on September 29, with Xinbao Co., Ltd. leading the drop [1] - The Shanghai Composite Index closed at 3862.53, up 0.9%, while the Shenzhen Component Index closed at 13479.43, up 2.05% [1] Stock Performance - Notable gainers in the small home appliance sector included: - Biyi Co., Ltd. (603215) with a closing price of 22.38, up 3.90% and a trading volume of 185,400 shares, totaling 422 million yuan [1] - ST Dehao (002005) closed at 2.40, up 3.45% with a trading volume of 168,000 shares, totaling 40.13 million yuan [1] - Major decliners included: - Xinbao Co., Ltd. (002705) with a closing price of 15.69, down 1.81% and a trading volume of 85,200 shares, totaling 133 million yuan [2] - Supor (002032) closed at 47.79, down 1.40% with a trading volume of 19,900 shares, totaling 95.41 million yuan [2] Capital Flow - The small home appliance sector saw a net outflow of 19.45 million yuan from institutional investors, while retail investors experienced a net outflow of 8.96 million yuan [2] - Conversely, speculative funds recorded a net inflow of 28.41 million yuan [2] Individual Stock Capital Flow - Biyi Co., Ltd. (603215) had a net outflow of 29.01 million yuan from institutional investors, with a net inflow of 10.83 million yuan from speculative funds [3] - Covos (603486) saw a net inflow of 17.62 million yuan from institutional investors, while retail investors had a net outflow of 15.22 million yuan [3] - Other notable stocks included: - ST Dehao (002005) with a net inflow of 3.48 million yuan from institutional investors [3] - Kaineng Health (300272) with a net inflow of 3.47 million yuan from institutional investors [3]

Core Viewpoint - The company, Kaineng Health, is entering the cell industry by establishing a wholly-owned subsidiary, Kaineng Cell Medical Group, with an investment of 100 million yuan, aiming to create a second growth curve through this strategic move [1][2]. Group 1: Business Expansion - Kaineng Health plans to focus on the cell and biotechnology sectors, covering areas such as medical aesthetics, medical research, drug clinical trials, and cosmetics production and sales [1][2]. - The establishment of the new subsidiary is part of the company's "dual energy drive" development strategy, aimed at strengthening its position in the cell industry and expanding its business footprint [2]. Group 2: Financial Performance - In the first half of 2025, Kaineng Health reported a revenue of 889 million yuan, a year-on-year increase of 7.23%, and a net profit attributable to shareholders of 70.15 million yuan, up 22.99% [1][2]. - The company's gross profit margin reached 41.12%, an increase of 0.62 percentage points compared to the same period last year, driven by improved production efficiency [2]. Group 3: Global Strategy - Kaineng Health is actively pursuing a "going global" strategy, establishing a comprehensive ecosystem and global layout across key markets in North America, Europe, and Asia-Pacific [3]. - The company has successfully expanded its water treatment products into over 100 countries and regions, with its Canadian subsidiary, Canature N.A.Inc., achieving a net profit of 23.97 million yuan in the reporting period [3]. Group 4: Industry Potential - The global cell therapy market is projected to exceed 30 billion USD by 2025, with a compound annual growth rate of over 20%, indicating significant growth potential for the company [4]. - Kaineng Health aims to leverage its existing water treatment business and the advantages of its partner, Yuaneng Group, in the cell industry to achieve synergistic development [5].

Investment Rating - The report maintains an "Outperform" rating for the company [1] Core Insights - The company is establishing a wholly-owned subsidiary in the cell industry, aiming to create a second growth curve alongside its existing business [6] - The company has seen growth in its export business, particularly in North America, while domestic sales are being enhanced through a new marketing service model [6] - The gross margin has improved due to increased production scale and digital management [6] - Profit forecasts for 2025 to 2027 indicate significant growth in net profit, with expected increases of 68%, 21%, and 7% respectively [6] Financial Data and Profit Forecast - Total revenue is projected to grow from 1,689 million in 2024 to 2,104 million by 2027, with a compound annual growth rate of approximately 8.2% [5][8] - The net profit attributable to the parent company is expected to rise from 140 million in 2025 to 183 million in 2027, reflecting a strong growth trajectory [5][8] - The company's gross margin is forecasted to stabilize around 39% from 2025 to 2027, indicating consistent profitability [5]

Key Points - Huasoft Technology is currently producing and selling light initiator products in small batches based on customer orders [1] - Kaineng Health plans to establish a wholly-owned subsidiary in Hainan or Hunan provinces to engage in the cell industry and related mergers and acquisitions [1] - Linyang Energy has won a bid for a 142 million yuan project with the State Grid [1] - New Zhizhi Software intends to acquire 49% equity of Shenzhen Hengdao for 48.2356 million yuan [1] - Xindian Software plans to repurchase shares worth between 30 million to 50 million yuan [1] - Shanjin International has submitted an application for the issuance and listing of H-shares on the Hong Kong Stock Exchange [1] - Zhongwei Semiconductor has also submitted an application for H-share issuance and listing on the Hong Kong Stock Exchange [1] - Huadong Heavy Machinery's Wu Qingming Yu No. 6 and Tianchen Jinting No. 1 plan to reduce their holdings by no more than 1.5% [2] - Xinde New Materials' Shang Rong Baoying and its concerted parties plan to reduce their holdings by no more than 3% [2] - Huayi Pharmaceutical's shareholder Wang Xiaopeng plans to reduce his holdings by no more than 12.708 million shares [2] - International Industry plans to raise no more than 660 million yuan through a private placement to its controlling shareholder [2] - Ruima Precision has been awarded a project for automotive air suspension system products [2] - Wanhui High-tech expects a net profit increase of 69.81% to 109.77% for the first three quarters [2]